News

Vanda claims that two generics to its sleep disorder drug Hetlioz were approved despite inadequate data and is requesting ...
There’s still much more to come from the White House on tariffs, but the European Union has now reached a trade agreement ...
With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...
While it’s impossible to make apples-to-apples comparisons of the many obesity candidates with so many differences across ...
Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...